Fundraising Fox

Protara Therapeutics

NASDAQ: TARA

Founded 2017 · 66 employees on LinkedIn · 1 known investors

Protara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.

BiotechHealthtechMedical Devices

Investors · 1

Catalio Capital Management, LPNew York

In the news

Janus Henderson Group (TARA holder) reports 8.4% Protara Therapeutics stake via Managed Portfoliosstocktitan.net · Aug 2026Protara Therapeutics (Nasdaq: TARA) posts Q1 loss and details TARA-002 plansstocktitan.net · May 2026Protara Therapeutics Announces $75 Million Public Offering of Common Stock and Pre-Funded Warrants | TARA Stock Newsquiverquant.com · Dec 2025

Frequently asked questions

What does Protara Therapeutics do?
Protara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.
Who are Protara Therapeutics's investors?
Protara Therapeutics's investors include Catalio Capital Management, LP.